スポンサーリンク
Takeda Chemical Industries Ltd. Pharmaceutical Research Division | 論文
- EFFECTS OF METHYL (+) (3S)-1,2,3,4-TETRAHYDRO-3-HYDROXY-METHYL-β-CARBOLINE-2-CARBODITHIOATE (THC), A NEW HEPATOPROTECTIVE AGENT, ON PROTEIN SYNTHESIS AND CHRONIC LIVER INJURY INDUCED BY CARBON TETRACHRORIDE IN RATS
- EFFECTS OF METHYL (+) (3S)-1,2,3,4-TETRAHYDRO-3-HYDROXYMETHYL-β-CARBOLINE-2-CARBODITHIOATE (THC), A NEW HEPATOPROTECTIVE AGENT, ON ACUTE LIVER INJURIES INDUCED BY VARIOUS HEPATOTOXIC SUBSTANCES IN MICE AND RATS
- Synthesis of 1,2,3,4-Tetrahydro-β-carboline Derivatives as Hepatoprotective Agents. IV. : Positional Isomers of 1,2,3,4-Tetrahydro-2-methylthiothiocarbonyl-β-carboline-3-carboxylic Acid and Its 1-Alkylated Derivatives(Medeicinal Chemistry,Chemical)
- Synthesis of 1,2,3,4-Tetrahydro-β-carboline Derivatives as Hepatoprotective Agents. III. : Introduction of Substituents onto Methyl 1,2,3,4-Tetrahydro-β-carboline-2-carbodithioate(Medeicinal Chemistry,Chemical)
- Synthesis of 1,2,3,4-Tetrahydro-β-carboline Derivatives as Hepatoprotective Agents. II. : Alkyl 1,2,3,4-Tetrahydro-β-carboline-2-carbodithioates(Medeicinal Chemistry,Chemical)
- PHARMACEUTICAL EVALUATION OF HOLLOW TYPE SUPPOSITORIES. V. PREPARATION OF VALPROIC ACID SUPPOSITORY AND RECTAL ABSORPTION OF VALPROIC ACID IN RABBITS
- PHARMACEUTICAL EVALUATION OF HOLLOW TYPE SUPPOSITORIES. IV. IMPROVEMENT OF BIOAVAILABILITY OF PROPRANOLOL IN RABBITS AFTER RECTAL ADMINISTRATION
- PHARMACEUTICAL EVALUATION OF HOLLOW TYPE SUPPOSITORY
- Studies of Drug Delivery Systems for a Therapeutic Agent Used in Osteoporosis. II. Enhanced Absorption of Elcatonin from Nasal Mucosa in Rabbits
- Studies on Disease-Modifying Antirheumatic Drugs. III. Bone Resorption Inhibitory Effects of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) and Related Compounds
- Studies on Disease-Modifying Antirheumatic Drugs. IV. Synthesis of Novel Thieno[2,3-b : 5,4-c']dipyridine Derivatives and Their Anti-inflammatory Effect
- Studies on Disease-Modifying Antirheumatic Drugs. II. Synthesis and Activity of the Metabolites of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603)
スポンサーリンク